Have a personal or library account? Click to login
Molecular Pathogenesis of Hepatocellular Carcinoma Cover

Molecular Pathogenesis of Hepatocellular Carcinoma

Balkan Journal of Medical Genetics
Volume 10 (2007): Issue 2 (December 2007)
By: S Metodieva  
Open Access
|May 2008

References

  1. Long XD, Ma Y, Wei YP, Deng ZL. The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res 2006; 36(1): 48-55.10.1016/j.hepres.2006.06.004
    Search in Google Scholar
  2. McKillop IH, Moran DM, Jin X, Koniaris LG. Molecular pathogenesis of hepatocellular carcinoma. J Surg Res 2006; 136(1): 125-135.10.1016/j.jss.2006.04.013
    Search in Google Scholar
  3. Nam SW, Park JY, Ramasamy A, Shevade S, Islam A, Long PM, Park CK, Park SE, Kim SY, Lee SH, Park WS, Yoo NJ, Liu ET, Miller LD, Lee JY. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology 2005; 42(4): 809-818.10.1002/hep.20878
    Search in Google Scholar
  4. Panga R, Tsea E, Poon RTP. Molecular pathways in hepatocellular carcinoma. Cancer Lett 2006; 240(2): 157-169.10.1016/j.canlet.2005.08.031
    Search in Google Scholar
  5. Hsiang C-Y, Wu S-L, Chen J-C, Lo H-Y, Li C-C, Chiang S-Y, Wu H-C, Ho T-Y. Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-κB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: association with the invasive potential. Toxicol Lett 2007; 171(1-2): 78-86.10.1016/j.toxlet.2007.04.009
    Search in Google Scholar
  6. Djordjević D, Nikolić J, Stefanović V. Ethanol interactions with other cytochrome P450 substrates including drugs, xenobiotics, and carcinogens. Pathol Biol 1998; 46(10): 760-70.
    Search in Google Scholar
  7. Buendia MA. Genetics of hepatocellular carcinoma. Semin Cancer Biol 2000; 10(3):185-200.10.1006/scbi.2000.0319
    Search in Google Scholar
  8. Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 2007; 27(1): 55-76.10.1055/s-2006-960171
    Search in Google Scholar
  9. Nishimura T, Nishida N, Komeda T, Fukuda Y, Ikai I, Yamaoka Y, Nakao K. Genome-wide semiquantitative microsatellite analysis of human hepatocellular carcinoma: discrete mapping of smallest region of overlap of recurrent chromosomal gains and losses. Cancer Genet Cytogenet 2006; 167(1): 57-65.10.1016/j.cancergencyto.2005.09.002
    Search in Google Scholar
  10. Buendia, MA. Tumor suppressors in hepatocellular carcinoma: many are called, but few are chosen. J Hepatol 2007; 46(4): 546-548.10.1016/j.jhep.2007.01.005
    Search in Google Scholar
  11. Pogribny IP, James SJ. Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation. Cancer Lett 2002; 176(2): 169-174.10.1016/S0304-3835(01)00748-0
    Search in Google Scholar
  12. Calvisi DF, Conner EA, Ladu S, Lemmer ER, Factor VM, Thogeirsson SS. Activation of the canonical Wnt/β-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. J Hepatol 2005; 42(6):842-849.10.1016/j.jhep.2005.01.029
    Search in Google Scholar
  13. Nakamoto Y, Guidotti LG, Kuhlen CV, Fowler P, Chisari FV. Immune pathogenesis of hepatocellular carcinoma. J Exp Med 1998; 188(2): 341-350.10.1084/jem.188.2.341
    Search in Google Scholar
  14. Li B, Gao B, Ye L, Han X, Wang W, Kong L, Fang X, Zeng Y, Zheng H, Li S, Wu Z, Ye L. Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response. Virus Res 2007; 124(1-2): 44-49.10.1016/j.virusres.2006.09.011
    Search in Google Scholar
  15. Cougot D, Neuveut C, Buendia MA. HBV-induced carcinogenesis. J Clin Virol 2005; 34(Suppl 1): S75-S78.10.1016/S1386-6532(05)80014-9
    Search in Google Scholar
  16. Zhang X, Zhang H, Ye L. Effects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med 2006; 147(2): 58-66.10.1016/j.lab.2005.10.00316459163
    Search in Google Scholar
  17. Cha C, DeMatteo RP. Molecular mechanisms in hepatocellular carcinoma development. Best Pract Res Clin Gastroenterol 2005; 19(1): 25-37.10.1016/j.bpg.2004.11.00515757803
    Search in Google Scholar
  18. Feitelson MA. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Lett 2006; 239(1): 10-20.10.1016/j.canlet.2005.07.00916154256
    Search in Google Scholar
  19. Wei W, Huang W, Pan Y, Zhu F, Wu J. Functional switch of viral protein HBx on cell apoptosis, transformation, and tumorigenesis in association with oncoprotein Ras. Cancer Lett 2006; 244(1): 119-128.10.1016/j.canlet.2005.12.00816569476
    Search in Google Scholar
  20. Kang-Park S, Lee JH, Shin JH, Lee YI. Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase signalings. Biochem Biophys Res Commun 2001; 283(2): 303-307.10.1006/bbrc.2001.476711327698
    Search in Google Scholar
  21. Kang-Park S, Im JH, Lee JH, Lee YI. PTEN modulates hepatitis B virus-X protein induced survival signaling in Chang liver cells. Virus Res 2006; 122(1-2): 53-60.10.1016/j.virusres.2006.06.01016872708
    Search in Google Scholar
  22. Henkler F, Hoare J, Waseem N, Goldin RD, McGarvey MJ, Koshy R, King IA. Intracellular localization of the hepatitis B virus HBx protein. J Gen Virol 2001; 82: 871-882.10.1099/0022-1317-82-4-871
    Search in Google Scholar
  23. Kim KM, Kwon S-N, Kang J-I, Lee SH, Jang SK, Ahn B-Y, Kim YK. Hepatitis C virus NS2 protein activates cellular cyclic AMP-dependent pathways. Biochem Biophys Res Commun 2007; 356(4): 948-954.10.1016/j.bbrc.2007.03.070
    Search in Google Scholar
  24. Baek K-H, Park H-Y, Kang C-M, Kim S-J, Jeong S-J, Hong E-K, Park J-W, Sung Y-C, Suzuki T, Kim C-M, Lee C-W. Overexpression of hepatitis C birus NS5A protein induces chromosome instability via mitotic cell cycle dysregulation. J Mol Biol 2006; 359(1): 22-34.10.1016/j.jmb.2006.03.020
    Search in Google Scholar
  25. Wang J, Tong W, Zhang X, Chen L, Yi Z, Pan T, Hu Y, Xiang L, Yuan Z. Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cells. FEBS Lett 2006; 580(18): 4392-4400.10.1016/j.febslet.2006.07.002
    Search in Google Scholar
  26. Basu A, Meyer K, Lai KK, Saito K, Di Bisceglie AM, Grosso LE, Ray RB, Ray R. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology 2006; 349(2): 347-358.10.1016/j.virol.2006.02.023
    Search in Google Scholar
  27. Nguyen H, Sankaran S, Dandekar S. Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes. Virology 2006; 354(1): 58-68.10.1016/j.virol.2006.04.028
    Search in Google Scholar
  28. Wang J-S, Groopman JD. DNA damage by mycotoxins. Mutat Res 1999; 424(1-2): 167-181.10.1016/S0027-5107(99)00017-2
    Search in Google Scholar
  29. Jackson PE, Groopman JD. Aflatoxin and liver cancer. Bailliere's Clin Gastroenterol 1999; 13(4): 545-555.10.1053/bega.1999.004710654919
    Search in Google Scholar
  30. Ming L, Thorgeirsson SS, Gail MH, Lu P, Harris CC, Wang N, Shao Y, Wu Z, Liu G, Wang X, Sun Z. Dominant Role of Hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology 2002; 36(5): 1214-1220.10.1053/jhep.2002.3636612395332
    Search in Google Scholar
  31. Asare GA, Bronz M, Naidoo V, Kew MC. Interactions between aflatoxin B1 and dietary iron overload in hepatic mutagenesis. Toxicology 2007; 234(3): 157-166.10.1016/j.tox.2007.02.00917399882
    Search in Google Scholar
  32. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004; 127(5): S87-S96.10.1053/j.gastro.2004.09.020
    Search in Google Scholar
  33. Balasubramaniyan V, Shukla R, Murugaiyan G, Bhonde RR, Nalini N. Mouse recombinant leptin protects human hepatoma HepG2 against apoptosis, TNF-α response and oxidative stress induced by the hepatotoxin-ethanol. Biochim Biophys Acta 2007; 1770(8): 1136-1144.10.1016/j.bbagen.2007.04.009
    Search in Google Scholar
  34. Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003; 34(1): 1-10.10.1016/S0891-5849(02)01167-X
    Search in Google Scholar
  35. McKillop IH, Schrum LW. Alcohol and liver cancer. Alcohol 2005; 35(3): 195-203.10.1016/j.alcohol.2005.04.00416054981
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10034-008-0002-4 | Journal eISSN: 2199-5761
Journal RSS Feed
Language: English
Page range: 15 - 22
Published on: May 30, 2008
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Aflatoxin,
Alcohol,
Hepatitis,
Hepatocellular carcinoma (HCC)
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2008 S Metodieva, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.

Volume 10 (2007): Issue 2 (December 2007)